Tag: American Diabetes Association
Semaglutide reduces risk for major kidney disease events in patients with...
Findings from the FLOW trial, the first dedicated kidney outcomes trial with a glucagon-like peptide-1 (GLP-1) receptor agonist were reported at a symposium at...
ATTEMPT study shows that SGLT2 inhibitors can improve kidney function in...
Findings from the ATTEMPT (The adolescent type 1 diabetes treatment with SGLT2i for hyperglycaemia and hyperfiltration trial) study that show that a low dose...